Extracellular-vesicle (exosome) products promoted for regenerative and aesthetic uses. NPHLA tracks their evidence and regulatory status.
Signal strength reflects editorial attention across tracked sources — not medical certainty or strength of evidence.
A system check is an automated check of the official sources, not a human review. An editorial review is recorded only when one of our editors has reviewed the page.
Every new official record on the Aesthetics, Regenerative & Longevity Medicine desk since this morning, each linked to its primary source.
Automated from official records13 sources1 min read
Not applicable, Cellese Inc.. Conditions: Skin Aging; Skin Quality. Interventions: Mechanical microneedling; AnteAGE Exosomes and PEARL Multiplier; AnteAGE Homecare Regimen. Investigational: trial-stage therapies are not approved for the use studied.
Phase 2, Banu Erkal. Conditions: Sjogren Syndrome; Xerostomia; Exosome. Interventions: exosomes derived from human umbilical cord mesenchymal stem cells; Mesenchymal Stem Cells (MSC); Placebo. Investigational: trial-stage therapies are not approved for the use studied.
